Alfredo Gamboa1, Sachin Y Paranjape2, Bonnie K Black2, Amy C Arnold2, Rocío Figueroa2, Luis E Okamoto2, Victor C Nwazue2, Andre Diedrich2, W Dale Plummer2, William D Dupont2, David Robertson2, Satish R Raj2. 1. From the Division of Clinical Pharmacology (A.G., S.Y.P., B.K.B., A.C.A., R.F., L.E.O., V.C.N., A.D., D.R., S.R.R.), Departments of Medicine (A.G., S.Y.P., B.K.B., A.C.A., R.F., L.E.O., V.C.N., A.D., D.R., S.R.R.), Pharmacology (D.R., S.R.R.), Biostatistics (W.D.P., W.D.D.), and Neurology (D.R.), Vanderbilt University, Nashville, TN; and Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Alberta, Canada (W.D.P., W.D.D.). alfredo.gamboa@vanderbilt.edu. 2. From the Division of Clinical Pharmacology (A.G., S.Y.P., B.K.B., A.C.A., R.F., L.E.O., V.C.N., A.D., D.R., S.R.R.), Departments of Medicine (A.G., S.Y.P., B.K.B., A.C.A., R.F., L.E.O., V.C.N., A.D., D.R., S.R.R.), Pharmacology (D.R., S.R.R.), Biostatistics (W.D.P., W.D.D.), and Neurology (D.R.), Vanderbilt University, Nashville, TN; and Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Alberta, Canada (W.D.P., W.D.D.).
Abstract
BACKGROUND: The objective of this study was to determine the effect of inspiratory resistance through an impedance threshold device (ITD) on orthostatic tolerance in patients with postural tachycardia syndrome. We hypothesized that the ITD would result in a greater negative intrathoracic pressure to enhance cardiac venous return, improve stroke volume, and reduce heart rate in these patients. METHODS AND RESULTS: We compared the effect of a sham device (sham, no resistance) versus an ITD (increased inspiratory resistance) in 26 patients with postural tachycardia syndrome in a randomized, single-blind, crossover study. Hemodynamic assessments were performed at baseline while supine and during head-up tilt to 70° for 10 minutes. We did not find differences in baseline hemodynamic parameters between the ITD and the sham devices. After 10 minutes of head-up tilt, the heart rate was lower with the ITD versus sham device (102±4 versus 109±4 beat/min, respectively; P=0.003). The ITD also improved stroke volume compared with the sham device (35±2 versus 26±1 mL; P=0.006). CONCLUSIONS: These findings suggest that increasing negative intrathoracic pressure with ITD breathing improves heart rate control in patients with postural tachycardia syndrome during upright posture. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov; Unique Identifier: NCT00962728.
RCT Entities:
BACKGROUND: The objective of this study was to determine the effect of inspiratory resistance through an impedance threshold device (ITD) on orthostatic tolerance in patients with postural tachycardia syndrome. We hypothesized that the ITD would result in a greater negative intrathoracic pressure to enhance cardiac venous return, improve stroke volume, and reduce heart rate in these patients. METHODS AND RESULTS: We compared the effect of a sham device (sham, no resistance) versus an ITD (increased inspiratory resistance) in 26 patients with postural tachycardia syndrome in a randomized, single-blind, crossover study. Hemodynamic assessments were performed at baseline while supine and during head-up tilt to 70° for 10 minutes. We did not find differences in baseline hemodynamic parameters between the ITD and the sham devices. After 10 minutes of head-up tilt, the heart rate was lower with the ITD versus sham device (102±4 versus 109±4 beat/min, respectively; P=0.003). The ITD also improved stroke volume compared with the sham device (35±2 versus 26±1 mL; P=0.006). CONCLUSIONS: These findings suggest that increasing negative intrathoracic pressure with ITD breathing improves heart rate control in patients with postural tachycardia syndrome during upright posture. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov; Unique Identifier: NCT00962728.
Authors: Qi Fu; Tiffany B Vangundy; M Melyn Galbreath; Shigeki Shibata; Manish Jain; Jeffrey L Hastings; Paul S Bhella; Benjamin D Levine Journal: J Am Coll Cardiol Date: 2010-06-22 Impact factor: 24.094
Authors: Walker B Plash; André Diedrich; Italo Biaggioni; Emily M Garland; Sachin Y Paranjape; Bonnie K Black; William D Dupont; Satish R Raj Journal: Clin Sci (Lond) Date: 2013-01 Impact factor: 6.124
Authors: Victor A Convertino; Kathy L Ryan; Caroline A Rickards; William H Cooke; Ahamed H Idris; Anja Metzger; John B Holcomb; Bruce D Adams; Keith G Lurie Journal: Crit Care Med Date: 2007-04 Impact factor: 7.598
Authors: Stephen W Smith; Brent Parquette; David Lindstrom; Anja K Metzger; Joni Kopitzke; Joseph Clinton Journal: J Emerg Med Date: 2010-07-15 Impact factor: 1.484
Authors: Shizue Masuki; John H Eisenach; William G Schrage; Christopher P Johnson; Niki M Dietz; Brad W Wilkins; Paola Sandroni; Phillip A Low; Michael J Joyner Journal: J Appl Physiol (1985) Date: 2007-07-12